{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:19:22Z","timestamp":1771953562359,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.exppara.2010.09.003","type":"journal-article","created":{"date-parts":[[2010,9,22]],"date-time":"2010-09-22T04:33:44Z","timestamp":1285130024000},"page":"376-381","source":"Crossref","is-referenced-by-count":21,"title":["Immunomodulatory effect of picroliv on the efficacy of paromomycin and miltefosine in combination in experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"127","author":[{"given":"Shraddha A.","family":"Sane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishi","family":"Shakya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2010.09.003_b0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus co-infection the first 10years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.exppara.2010.09.003_b0010","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod immunomodulator","volume":"33","author":"Arevalo","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.exppara.2010.09.003_b0015","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00002030-199910010-00015","article-title":"HIV viral load and response to antileishmanial chemotherapy in co-infected patients","volume":"13","author":"Berhe","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.exppara.2010.09.003_b0020","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis","volume":"43","author":"Bern","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.exppara.2010.09.003_b0025","first-page":"439","article-title":"Exploration of antileishmanial activity in heterocycles results of their in vivo & in vitro bioevaluations","volume":"89","author":"Bhatnagar","year":"1989","journal-title":"Indian Journal of Medical Research"},{"key":"10.1016\/j.exppara.2010.09.003_b0030","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance","volume":"6","author":"Bryceson","year":"2001","journal-title":"Tropical Medicine & International Health"},{"key":"10.1016\/j.exppara.2010.09.003_b0035","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.exppara.2010.09.003_b0040","first-page":"324","article-title":"Picroliv affects gamma-glutamyl cycle in liver and brain of Mastomys natalensis infected with Plasmodium berghei","volume":"32","author":"Chander","year":"1994","journal-title":"Indian Journal of Experimental Biology"},{"key":"10.1016\/j.exppara.2010.09.003_b0045","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nature Reviews Microbiology"},{"key":"10.1016\/j.exppara.2010.09.003_b0050","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/0006-2952(87)90543-0","article-title":"The activity of alkyl phosphocholines and related derivates against Leishmania donovani","volume":"36","author":"Croft","year":"1987","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.exppara.2010.09.003_b0055","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.trstmh.2008.09.008","article-title":"Paromomycin","volume":"103","author":"Davidson","year":"2009","journal-title":"Transactions of Royal Society of Tropical Medicine & Hygiene"},{"key":"10.1016\/j.exppara.2010.09.003_b0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0773.1992.tb00566.x","article-title":"Picroliv and its components kutkoside and picroside I protect liver against galactosamine-induced damage in rats","volume":"71","author":"Dwivedi","year":"1992","journal-title":"Pharmacology and Toxicology"},{"key":"10.1016\/j.exppara.2010.09.003_b0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.actatropica.2004.11.009","article-title":"Efficacy of picroliv combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis","volume":"94","author":"Gupta","year":"2005","journal-title":"Acta Tropica"},{"key":"10.1016\/j.exppara.2010.09.003_b0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1081\/IPH-200026895","article-title":"Adjunct effect of immunostimulating hexapeptide analogous to human beta-casein fragment (54\u201359) to sodium stibogluconate against experimental visceral leishmaniasis","volume":"26","author":"Gupta","year":"2004","journal-title":"Immunopharmacology and Immunotoxicology"},{"key":"10.1016\/j.exppara.2010.09.003_b0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.exppara.2006.12.004","article-title":"Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator imiquimod","volume":"116","author":"El-On","year":"2007","journal-title":"Experimental Parasitology"},{"key":"10.1016\/j.exppara.2010.09.003_b0080","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response","volume":"166","author":"Melby","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.exppara.2010.09.003_b0085","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/infdis\/157.5.973","article-title":"Immunotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony","volume":"157","author":"Murray","year":"1988","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.exppara.2010.09.003_b0090","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI114009","article-title":"Requirement for T cells and effects of lymphokines in successful chemotherapy for an intracellular infection: experimental visceral leishmaniasis","volume":"83","author":"Murray","year":"1989","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.exppara.2010.09.003_b0095","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10534-008-9150-y","article-title":"Comparative efficacy of piperine, curcumin and picroliv against Cd immunotoxicity in mice","volume":"21","author":"Pathak","year":"2008","journal-title":"Biometals"},{"key":"10.1016\/j.exppara.2010.09.003_b0100","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-2006-961542","article-title":"Immunostimulant activity of picroliv, the iridoid glycoside fraction of Picrorhiza kurroa, and its protective action against Leishmania donovani infection in hamsters","volume":"58","author":"Puri","year":"1992","journal-title":"Planta Medica"},{"key":"10.1016\/j.exppara.2010.09.003_b0105","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.intimp.2004.12.015","article-title":"Immunomodulatory activity of analog of muramyl dipeptide and their use as adjunct to chemotherapy of Leishmania donovani in hamster","volume":"5","author":"Puri","year":"2005","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.exppara.2010.09.003_b0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF02867970","article-title":"Antioxidant activity of ethanol extract of rhizome of Picrorhiza kurroa on indomethacin induced gastric ulcer during healing","volume":"17","author":"Ray","year":"2002","journal-title":"Indian Journal of Clinical Biochemistry"},{"key":"10.1016\/j.exppara.2010.09.003_b0115","first-page":"316","article-title":"Anticholestatic effect of picroliv, active hepatoprotective principle of Picrorhiza kurrooa, against carbon tetrachloride induced cholestasis","volume":"31","author":"Saraswat","year":"1993","journal-title":"Indian Journal of Experimental Biology"},{"key":"10.1016\/j.exppara.2010.09.003_b0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","article-title":"In vitro and in vivo interactions between miltefosine and other antileishmanial drugs","volume":"50","author":"Seifert","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.exppara.2010.09.003_b0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00024382-200302000-00014","article-title":"Picroliv modulates antioxidant status and down-regulates AP1 transcription factor after hemorrhage and resuscitation","volume":"19","author":"Seth","year":"2003","journal-title":"Shock"},{"key":"10.1016\/j.exppara.2010.09.003_b0130","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1189\/jlb.0903415","article-title":"Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocyte: modulatory effect of nitric oxide","volume":"75","author":"Sharma","year":"2004","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.exppara.2010.09.003_b0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S0031182003003457","article-title":"Prophylactic potential of autoclaved Leishmania donovani with BCG against experimental visceral leishmaniasis","volume":"127","author":"Shrivastava","year":"2003","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2010.09.003_b0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3347\/kjp.2006.44.1.55","article-title":"Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB\/c mice","volume":"44","author":"Solgi","year":"2006","journal-title":"Korean Journal of Parasitology"},{"key":"10.1016\/j.exppara.2010.09.003_b0145","first-page":"345","article-title":"Visceral leishmaniasis \u2013 current therapeutic modalities","volume":"123","author":"Sundar","year":"2006","journal-title":"Indian Journal of Medical Research"},{"key":"10.1016\/j.exppara.2010.09.003_b0150","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for visceral leishmaniasis in India","volume":"356","author":"Sundar","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.exppara.2010.09.003_b0155","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Tropical Medicine & International Health"},{"key":"10.1016\/j.exppara.2010.09.003_b0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0009-8981(03)00086-X","article-title":"Flow cytometry study of polymorphonuclear neutrophil oxidative burst: a comparison of three fluorescent probes","volume":"331","author":"Walrand","year":"2003","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.exppara.2010.09.003_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/096032706072455","article-title":"Effect of picroliv on cadmium-induced hepatic and renal damage in the rat","volume":"25","author":"Yadav","year":"2006","journal-title":"Human Experimental Toxicology"},{"key":"10.1016\/j.exppara.2010.09.003_b0170","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.fct.2007.08.035","article-title":"Effect of picroliv on cadmium-induced testicular damage in the rat","volume":"46","author":"Yadav","year":"2008","journal-title":"Food and Chemical Toxicology"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489410003127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489410003127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T20:22:35Z","timestamp":1559679755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489410003127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0014489410003127"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2010.09.003","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}